These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 26651495)
1. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients. Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495 [TBL] [Abstract][Full Text] [Related]
2. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666 [TBL] [Abstract][Full Text] [Related]
3. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases. Ranawaka RR; Nagahawatte A; Gunasekara TA Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159 [TBL] [Abstract][Full Text] [Related]
4. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK; Lynde CW; Konnikov N J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
6. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK; Gover MD; Lynde CW J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
8. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481 [TBL] [Abstract][Full Text] [Related]
10. Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis. Bahadir S; Inalöz HS; Alpay K; Agaoglu C; Cimsit G; Parlat P J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):422-3. PubMed ID: 11305391 [No Abstract] [Full Text] [Related]
11. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776 [TBL] [Abstract][Full Text] [Related]
12. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis. Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131 [TBL] [Abstract][Full Text] [Related]
13. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Jaiswal A; Sharma RP; Garg AP Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857 [TBL] [Abstract][Full Text] [Related]
14. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. Tosti A; Piraccini BM; Stinchi C; Venturo N; Bardazzi F; Colombo MD J Am Acad Dermatol; 1996 Apr; 34(4):595-600. PubMed ID: 8601647 [TBL] [Abstract][Full Text] [Related]
15. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. Heikkilä H; Stubb S Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235 [TBL] [Abstract][Full Text] [Related]
16. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. Evans EG; Sigurgeirsson B BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099 [TBL] [Abstract][Full Text] [Related]
17. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in the treatment of toenail onychomycosis. De Cuyper C; Hindryckx PH Br J Dermatol; 1999 Nov; 141 Suppl 56():15-20. PubMed ID: 10730909 [TBL] [Abstract][Full Text] [Related]
19. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis. Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908 [TBL] [Abstract][Full Text] [Related]
20. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial. De Backer M; De Keyser P; De Vroey C; Lesaffre E Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]